What is the medical name for an abdominal morphine (opioid analgesic) pump?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medical Terminology for Abdominal Morphine Pump

The medical name for an abdominal morphine pump is an "intrathecal drug delivery system" (ITDDS) or "intrathecal pump," which delivers opioid analgesics directly into the intrathecal space of the spinal canal via an implantable programmable pump. 1

Specific Terminology and Components

The system consists of several key components with precise medical nomenclature:

  • Intrathecal (i.t.) implantable pump: The fully implanted programmable device that is surgically placed in the abdominal wall 1
  • Intrathecal catheter: The delivery catheter that runs from the pump to the intrathecal space, typically inserted at the lumbar level 1
  • Alternative terms: "Implantable infusion pump," "programmable pump," or "subcutaneous pump" are also used in the literature 2, 3

Distinguishing from Related Systems

It is important to differentiate this from other spinal drug delivery methods:

  • Epidural catheter systems: Deliver medication into the epidural space rather than the intrathecal space, requiring higher doses (20-40% of systemic dose vs. only 10% for intrathecal) 1
  • Percutaneous or tunneled catheters: Temporary external systems that do not involve a fully implanted pump 1
  • Subcutaneous reservoir (Spinalgesic): An injectable reservoir system that requires manual bolus injections rather than continuous infusion 2

Clinical Context

The intrathecal route requires dramatically lower doses compared to other routes: only 1/300th of the oral morphine dose and 1/24th of the epidural dose for equivalent analgesia 1, 4. The fully implanted systems offer significantly lower infection risk and require less maintenance than percutaneous routes, though positioning is more complex 1. These systems are indicated for patients with life expectancy greater than 6 months who have failed conservative management and demonstrated at least 50% pain reduction during a trial period 1, 4, 5.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.